HOME › DRUGS › RELATLIMAB;NIVOLUMAB
ACTIVE SUBSTANCE / INN

RELATLIMAB;NIVOLUMAB

Brand name(s): Opdualag
EMA LISTED
AUTHORISED
Melanoma
ACTIVE SUBSTANCE
Relatlimab;Nivolumab
REGULATORS
EMA
SPONSORS / MAH
Bristol-Myers Squibb Pharma EEIG
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
OpdualagBristol-Myers Squibb Pharma EEIGAuthorised15/09/2022Melanoma

FULL INTELLIGENCE ON RELATLIMAB;NIVOLUMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →